10 Box (MOQ)
Business Type | Manufacturer, Exporter, Supplier |
Brand Name | Intajac |
Usage/Application | Hospital |
Packaging Type | Strips |
Click to view more |
Product Details
Tofacitinib, also known as Xeljanz, is a type of drug known as a Janus kinase (JAK) inhibitor. It works by blocking the action of Janus kinase enzymes, which are involved in the inflammation that causes the symptoms of rheumatoid arthritis and psoriatic arthritis.
Tofacitinib is a long-term treatment. Most people who benefit from this treatment will notice an improvement the first 12 weeks of starting treatment.
Hi! Simply click below and type your query.
Our experts will reply you very soon.